Skip to main content
[Preprint]. 2021 Apr 29:2021.04.26.21256016. [Version 1] doi: 10.1101/2021.04.26.21256016

Figure 2: Seroprevalence of SARS-CoV-2 antibodies in Mali.

Figure 2:

Figure 2:

Seroprevalence adjusted for population age distribution and assay sensitivity and specificity [15].

Error bars represent 95% confidence intervals.

Asterisk represents p<0.0001 in comparison between sites.

Longitudinal SARS-CoV-2 antibody reactivity spike protein and RBD at study sites: Sotuba (top row), Bancoumana (middle row) and Donéguébougou (bottom row).

RBD: receptor binding domain, OD: optical density

Visit 1: 28 July to 16 October 2020

Visit 2: 14 December 2020 to 29 January 2021